Among many kinds of somatic stem cells, hematopoietic stem cells are the cells that have been successfully applied to treating leukemia patients as forms of bone marrow and cord blood transplantation. Mesenchymal stem cells, collectable from several sources including the bone marrow and adipose tissue, are also widely applied to clinical trials for their easy accessibility and low risks of tumorigenesis, while their outcomes were shown to be not clinically relevant in several target diseases. The most important issue for the stem cells is whether the cells are safe and effective for curing diseases. In this chapter, the outline of the clinical trial in Muse cells is discussed.
CITATION STYLE
Dezawa, M. (2018). Clinical trials of muse cells. In Advances in Experimental Medicine and Biology (Vol. 1103, pp. 305–307). Springer New York LLC. https://doi.org/10.1007/978-4-431-56847-6_17
Mendeley helps you to discover research relevant for your work.